exRNAdisease

Entry Detail

---



General Information

Database ID: exR0267125 RNA Name: hsa-miR-330-5p RNA Type: miRNA Chromosome: chr19 Starnd: - Coordinate: Start Site(bp): 45639049 End Site(bp): 45639070 External Links: hsa-miR-330-5p

Disease Information

Disease Name: Cystic Fibrosis Disease Category: Congenital, Hereditary, and Neonatal Diseases and Abnormalities MeSH ID: D003550 Type: Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities Alias: Fibrosis, Cystic//Mucoviscidosis//Pulmonary Cystic Fibrosis//Cystic Fibrosis, Pulmonary//Pancreatic Cystic Fibrosis//Cystic Fibrosis, Pancreatic//Fibrocystic Disease of Pancreas//Pancreas Fibrocystic Disease//Pancreas Fibrocystic Diseases//Cystic Fibrosis of Pancreas

Expression Detail

GEO ID: GSE135119 Description: Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis Experimental Design: Disease vs Control Case Disease Type: Cystic Fibrosis Case Disease SubType: NA Case Sample: Cystic Fibrosis Control Sample: Healthy Number of Case: 5 Number of Control: 5 Number of Samples: 10

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand ZNF3 chr7 100064033 100082548 - ALDH5A1 chr6 24494867 24537207 + ENG chr9 127815012 127854756 - NEMP1 chr12 57055643 57088063 - STX3 chr11 59713456 59805882 + RTL10 chr22 19846138 19854896 - GIPC1 chr19 14477760 14496149 - ANKRD13B chr17 29589769 29614761 + UBE4A chr11 118359585 118399211 + MARK2 chr11 63838928 63911019 + ATXN1 chr6 16299112 16761491 - NME4 chr16 396725 410367 + TMEM127 chr2 96248516 96265994 - PDXK chr21 43719094 43762307 + GUCD1 chr22 24540423 24555935 - MTG2 chr20 62183029 62203568 + VLDLR chr9 2621787 2660056 + EIF4A1 chr17 7572706 7579006 + GIGYF1 chr7 100679507 100694037 - DOLPP1 chr9 129081111 129090438 + SMAD3 chr15 67063763 67195169 + MAP4 chr3 47850690 48089272 - ABL1 chr9 130713016 130887675 + PAQR4 chr16 2969270 2973484 + NR4A2 chr2 156324437 156342348 - CRTC3 chr15 90529923 90645345 + PPME1 chr11 74171267 74254703 + GOSR2 chr17 46923075 46975524 + MYO1C chr17 1464186 1492686 - AGTRAP chr1 11736084 11754802 + miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000128 chr1 151139409 151139890 + hsa_circ_0000384 chr12 27867712 27877119 + hsa_circ_0001727 chr7 99621041 99621930 + hsa_circ_0001865 chr9 86292641 86293514 - lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC016876.2 chr17 7581964 7584086 - AC144548.1 chr12 110387463 110445548 - AL355075.4 chr14 20343048 20343685 - AL359924.1 chr1 237862175 237928321 + AP000553.1 chr22 21652270 21670237 + KCNQ1OT1 chr11 2608328 2699994 - MIRLET7BHG chr22 46053869 46113928 + NEAT1 chr11 65422774 65445540 + SNHG1 chr11 62851984 62855953 - SNHG3 chr1 28505980 28510892 + TUG1 chr22 30969245 30979395 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE135119 Sample Source: Blood Source Fraction: Plasma Platform: GPL19117 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2346 Sample treatment protocol: NA RNA Extract protocol: Frozen samples; Mixture with Trizol Reagent followed by extraction with RNA Clean and Concentrator kit. RNA library preparation protocol: Using the Affymetrix GeneChip miRNA 4.0 array, 8ul of plasma from each sample was labelled using FlashTag Biotin RNA Labelling kit.

Reference

PMID: 31664087 Title: Microarray profiling identifies extracellular circulating miRNAs dysregulated in cystic fibrosis Author: Ideozu JE, Zhang X, Rangaraj V, McColley S, Levy H Journal: Sci Rep. 2019 Oct 29;9(1):15483. Description: we employed microarray technology to identify aberrantly expressed plasma ECmiRNAs in CF and elucidate the functional relevance of their targets.